期刊文献+

复发卵巢癌的化疗效果研究 被引量:8

下载PDF
导出
摘要 目的研究复发卵巢癌手术治疗和化疗治疗方案的临床效果。方法回顾性总结45例复发性卵巢癌的临床病理资料,探讨复发卵巢癌手术治疗和化疗治疗方法的选择。根据患者复发时个体病情选择性行肿瘤细胞减灭术和二线化疗,顺铂敏感型加大顺铂剂量,顺铂耐药或不敏感患者,二线化疗给予紫杉醇加顺铂方案或紫杉醇加卡铂方案。结果行二次肿瘤细胞减灭术,1年、2年和3年生存率分别为68.42%、52.63%和47%。单纯进行二线化疗,1年、2年和3年生存率分别为88.46%、76.92%和69.23%。结论针对患者个体情况确定复发后治疗方案,慎选二次手术治疗,化疗方案可有效改善患者生活质量。
出处 《河北医药》 CAS 2009年第4期448-449,共2页 Hebei Medical Journal
  • 相关文献

参考文献5

  • 1Alberts DS, Hannigan EV,Liu PY,et al. Randomized trial of adjuvant intrap- eritoneal alpha-interferon in stage Ⅲ ovarian cancer patients who have no evidence of disease after primary surgery and chemotherapy: an intergroup study. Gynecol Oncol,2006, 100:133-138.
  • 2王莉芹,李小平,崔衡.卵巢癌腹腔化疗应用现状[J].河北医药,2006,28(11):1095-1096. 被引量:2
  • 3陈忠朴,孙会平.胃复安穴位治疗卵巢癌化疗性胃肠反应[J].河北医药,2007,29(6):601-601. 被引量:2
  • 4Salzberg M, Thurlimann B, Bonnefois H, et al. current concepts of treatment strategies in advanced or recurrent ovarian cancer. Oncology, 2005,68: 293- 298.
  • 5Choan C, Quon M, Gallant V, et al. Effective palliative radiotherapy for symp- tomatic recurrent or residual ovarian cancer. Gynccol Oncol, 2006, 102: 204- 209.

二级参考文献16

  • 1何广贤.缺锌综合征证治浅谈[J].新中医,1993,25(11):11-12. 被引量:3
  • 2丁菊英,赵粹英,吴恒举,居贤水,黎飒,张英英.艾灸对老年人红细胞免疫及自由基的影响[J].上海针灸杂志,1995,14(1):4-5. 被引量:46
  • 3中山医学院肿瘤医院妇科.卵巢恶性肿瘤123例临床分析[J].新医学,1974,5(11):544-544.
  • 4Coil J, Castano R, Toziano M, et al. Intraperitoneal hyperthermic chemotherapy in ovariancancer. Int J Gynecol Cancer, 2005,15 : 233-239.
  • 5Toumigand C. Intraperitoneal chemotherapy in ovarian cancer: who and when? Curr Opin Obstet Gynecol, 2005,17 : 83-86.
  • 6Dedrick RL.Theoretical and experimental bases of intrperitoneal chemotherapy. Semin Oncol, 1985,12 (suppl4) : 1-5.
  • 7Markman M, Reichaman B, hakes T, et al. Intraperitoneal chemotherapy in the management of ovarian cancer.Yale I Biol Med, 1993,71 : 1565-1571.
  • 8Alberts DS, Liu Py, Hannigan EV, et al. Intraperitoneal cisplatin plus in trarenous cisplatin plus intravenous cyclophvs phamide for stage 3 ovarianeancer. N Engl J Med, 1996,335:1 950-1 955.
  • 9Markman M, Bundy BN,Alberts DS,et al. Phase3 trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplat in small-volume stage 3 ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group. J Clin Oncol,2001,19: 1001-1007.
  • 10Rothenberg ML, Liu PY, Braly PS, et al. Combined intraperirtoneal and intravenous chemotherapy for woman with optimally debulked ovarian cancer: resuits from an intergroup phase2 tfial.J Clin Oncol,2003,21 : 1313-1319.

共引文献2

同被引文献93

引证文献8

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部